App-Quantinova.ai

Optimal Peri-endoscopic Management of Anti-thrombotic Therapy in Chinese Elderly Patients: A Retrospective Study

Tao Tao - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

New Oral Anticoagulants: Bleeding Rates Among Medicare Beneficiaries with Atrial Fibrillation

Jeremy Smith - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

rivaroxaban

Clinical Implementation of CYP2C19-genotype Guided Antiplatelet Therapy Reduces Cardiovascular Events After PCI

Oyunbileg Magvanjav - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Clopidogrel bisulfate

Prevalence of Platelet Non-resposiveness to Aspirin by Thromboelastography (teg) in Children with Congenital Heart Disease: An Institutional Experience

Stephanie Ghaleb - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

Aspirin

Antiplatelet Activity and Clinical Outcomes on CYP3A4-metabolized Statin in Percutaneous Coronary Intervention

Kwang Soo Cha - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

Long (>12 Months) and Short (<6 Months) versus Standard Duration of Dual Antiplatelet Therapy After Coronary Stenting: A Systematic Review and Meta-analysis

Alexandros Briasoulis - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Severity Assessment of Coronary Artery Aneurysm by Z-score of the Internal Diameter in Kawasaki Disease

Naoya Fukushima - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Bleeding Risk and Major Adverse Events in Patients with Cancer on Oral Anticoagulation Therapy

Jin-Kyu Park - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

The Safety and Efficacy of Platelet Glycoprotein Iib Iiia Antagonist by Intracoronary Administration versus Intravenous Administration in Patients with St Segment Elevation Myocardial Infarction: A Meta-analysis

Jun Pang - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

The Impact of Anti-angiogenic Isoform of Vascular Endothelial Growth Factor A in Patients with Pulmonary Hypertension

Kazuhiko Nakakzato - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Incidence of Stent Thrombosis and its Predictors After Endovascular Therapy for Femoropopliteal Artery Disease

Osamu Iida - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Impact of Multiple Plaque Ruptures and Cavity Area on Intraprocedural Stent Thrombosis: Intravascular Ultrasound Analysis

Shinji Inaba - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Continuous Smoking Promotes Neoatherosclerosis Formation in Stent Restenotic Neointimal Tissue After Drug-eluting Stent Implantation

Satoshi Ichimiya - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Clinical and Echocardiographic Predictors of Bioprosthetic Valve Thrombosis

Sorin V Pislaru - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Beat-to-beat Systolic as Well as Diastolic Blood Pressure Variability is High in Atrial Fibrillation

Adam Gille - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

RVX-208 a Selective Bromodomain and Extra-terminal BET Protein Inhibitor Acts on Several Pathways to Benefit Cardiovascular Risks

Ewelina Kulikowski - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

RVX-208

Extracellular Matrix Remodelling in Porcine Coronary Arteries Upon Stent Implantation

Wojtek Wojakowski - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Coronary Stent Information via Smartphone: A New Application Improving Health-care Quality of Patients Having Undergone Percutaneous Coronary Intervention

Takayoshi Yagi - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Association of Atrial Fibrosis with Major Adverse Cardiac Events in Patients with Non-valvular Atrial Fibrillation

Mukul Singhal - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The Effect of Cangrelor on Cardiovascular and Bleeding Events in Patients with Peripheral Artery Disease - Insights From CHAMPION PHOENIX

Robert A Harrington - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

Filters

7277 Abstracts